ANCEF Drug Patent Profile
✉ Email this page to a colleague
When do Ancef patents expire, and when can generic versions of Ancef launch?
Ancef is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.
The generic ingredient in ANCEF is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ancef
A generic version of ANCEF was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
Summary for ANCEF
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 64 |
Patent Applications: | 2,824 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ANCEF at DailyMed |